Study assesses the safety, efficacy of using immune checkpoint inhibitors in patients with advanced kidney cancer

E

Educator

New member
Patients with advanced kidney cancer are routinely given immune checkpoint inhibitors (ICIs) as first-line treatment.
 
You must log in or register to reply here.
Top
AdBlock Detected

We get it, advertisements are annoying!

Sure, ad-blocking software does a great job at blocking ads, but it also blocks useful features of our website. For the best site experience please disable your AdBlocker.

I've Disabled AdBlock